4/A//SEC Filing
Nolan Garry Ph.D. 4/A
Accession 0001104659-23-037255
CIK 0001711933other
Filed
Mar 26, 8:00 PM ET
Accepted
Mar 27, 8:12 PM ET
Size
4.8 KB
Accession
0001104659-23-037255
Insider Transaction Report
Form 4/AAmended
Nolan Garry Ph.D.
Director
Transactions
- Sale
Common Stock
2022-12-13$13.25/sh−100$1,325→ 555,084 total
Footnotes (1)
- [F1]The Form 4/A is being filed to correct the date of the transaction which was inadvertently reported as occurring on 12/13/2021.
Documents
Issuer
Akoya Biosciences, Inc.
CIK 0001711933
Entity typeother
Related Parties
1- filerCIK 0001857405
Filing Metadata
- Form type
- 4/A
- Filed
- Mar 26, 8:00 PM ET
- Accepted
- Mar 27, 8:12 PM ET
- Size
- 4.8 KB